Information:
Fel:
ID
41210
Beskrivning
Immunologic Response After Pandemic Influenza A (H1N1) Vaccine in Onco- Hematologic Patients; ODM derived from: https://clinicaltrials.gov/show/NCT01394640
Länk
https://clinicaltrials.gov/show/NCT01394640
Nyckelord
Versioner (1)
- 2020-07-14 2020-07-14 -
Rättsinnehavare
See clinicaltrials.gov
Uppladdad den
14 juli 2020
DOI
För en begäran logga in.
Licens
Creative Commons BY 4.0
Modellkommentarer :
Här kan du kommentera modellen. Med hjälp av pratbubblor i Item-grupperna och Item kan du lägga in specifika kommentarer.
Itemgroup-kommentar för :
Item-kommentar för :
Du måste vara inloggad för att kunna ladda ner formulär. Var vänlig logga in eller registrera dig utan kostnad.
Eligibility Lymphoma NCT01394640
Eligibility Lymphoma NCT01394640
- StudyEvent: Eligibility
Similar models
Eligibility Lymphoma NCT01394640
- StudyEvent: Eligibility
Name
Typ
Description | Question | Decode (Coded Value)
Datatyp
Alias
Age
Item
age ≥18 years
boolean
C0001779 (UMLS CUI [1])
Patient Oncologic Hematologic | influenza virus vaccine, H1N1 Planned
Item
oncologic and hematologic patient with the plan of receiving the a (h1n1) vaccine
boolean
C0030705 (UMLS CUI [1,1])
C0205478 (UMLS CUI [1,2])
C0205488 (UMLS CUI [1,3])
C2722215 (UMLS CUI [2,1])
C1301732 (UMLS CUI [2,2])
C0205478 (UMLS CUI [1,2])
C0205488 (UMLS CUI [1,3])
C2722215 (UMLS CUI [2,1])
C1301732 (UMLS CUI [2,2])
Control Group | Oncologic disorders | Hematological Disease | influenza virus vaccine, H1N1 Planned
Item
control group: a silent history for oncologic and hematologic diseases; planned of receiving the a (h1n1) vaccine
boolean
C0009932 (UMLS CUI [1])
C3853943 (UMLS CUI [2])
C0018939 (UMLS CUI [3])
C2722215 (UMLS CUI [4,1])
C1301732 (UMLS CUI [4,2])
C3853943 (UMLS CUI [2])
C0018939 (UMLS CUI [3])
C2722215 (UMLS CUI [4,1])
C1301732 (UMLS CUI [4,2])
Informed Consent
Item
written informed consent
boolean
C0021430 (UMLS CUI [1])
Immune Globulin Infusion
Item
infusion of human immunoglobulin ongoing or within prior 30 days
boolean
C0358321 (UMLS CUI [1,1])
C0574032 (UMLS CUI [1,2])
C0574032 (UMLS CUI [1,2])
Monoclonal Antibody Therapy | Polyclonal antibody
Item
therapy with monoclonal or polyclonal antibodies ongoing or within prior 30 days
boolean
C0279694 (UMLS CUI [1])
C0312586 (UMLS CUI [2])
C0312586 (UMLS CUI [2])
IL-1 therapy | Interleukin-2 therapy | Gamma interferon therapy
Item
therapy with il-1 or il-2 or ifn-gamma ongoing or within prior 30 days
boolean
C0860386 (UMLS CUI [1])
C0199975 (UMLS CUI [2])
C0854623 (UMLS CUI [3])
C0199975 (UMLS CUI [2])
C0854623 (UMLS CUI [3])
Autologous peripheral blood stem cell transplant | Allogeneic peripheral blood stem cell transplant
Item
autologous pbsct less than 1 month or allogeneic pbsct less than 6 months
boolean
C1960579 (UMLS CUI [1])
C1960580 (UMLS CUI [2])
C1960580 (UMLS CUI [2])
Pregnancy | Breast Feeding
Item
pregnancy or lactation
boolean
C0032961 (UMLS CUI [1])
C0006147 (UMLS CUI [2])
C0006147 (UMLS CUI [2])
Hypersensitivity type
Item
type i hypersensitivity
boolean
C0441750 (UMLS CUI [1])
Anticoagulant therapy | Platelet Count measurement
Item
ongoing anticoagulant therapy or platelets < 50000/ul
boolean
C0150457 (UMLS CUI [1])
C0032181 (UMLS CUI [2])
C0032181 (UMLS CUI [2])